125 related articles for article (PubMed ID: 12468204)
1. Anti-tumor effect of Merocyanine 540-mediated photochemotherapy combined with Edelfosine: potential implications for the ex vivo purging of hematopoietic stem cell grafts from breast cancer patients.
Anderson GS; Miyagi K; Sampson RW; Sieber F
J Photochem Photobiol B; 2002 Nov; 68(2-3):101-8. PubMed ID: 12468204
[TBL] [Abstract][Full Text] [Related]
2. Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts.
Anderson GS; Tsujino I; Miyagi K; Sampson R; Sieber F
J Photochem Photobiol B; 2003 Feb; 69(2):87-95. PubMed ID: 12633981
[TBL] [Abstract][Full Text] [Related]
3. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.
Tsujino I; Miyagi K; Sampson RW; Sieber F
Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499
[TBL] [Abstract][Full Text] [Related]
5. Crystal violet combined with Merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts.
Miyagi K; Sampson RW; Sieber-Blum M; Sieber F
J Photochem Photobiol B; 2003 Jul; 70(3):133-44. PubMed ID: 12962637
[TBL] [Abstract][Full Text] [Related]
6. Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts.
Yamazaki T; Sato Y; Sieber F
Exp Hematol; 1997 Jul; 25(7):629-37. PubMed ID: 9216739
[TBL] [Abstract][Full Text] [Related]
7. Postirradiation hyperthermia selectively potentiates the merocyanine 540-sensitized photoinactivation of small cell lung cancer cells.
Tsujino I; Anderson GS; Sieber F
Photochem Photobiol; 2001 Feb; 73(2):191-8. PubMed ID: 11272734
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of merocyanine 540-mediated photodynamic therapy by salicylate and related drugs.
Traul DL; Anderson GS; Bilitz JM; Krieg M; Sieber F
Photochem Photobiol; 1995 Oct; 62(4):790-9. PubMed ID: 7480156
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?
Traul DL; Sieber F
J Photochem Photobiol B; 2015 Dec; 153():153-63. PubMed ID: 26410039
[TBL] [Abstract][Full Text] [Related]
10. Effect of hypothermia on the merocyanine 540-mediated purging of hematopoietic cells.
Yamazaki T; Sieber F
J Hematother; 1997 Feb; 6(1):31-9. PubMed ID: 9112216
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal photochemotherapy.
Tsujino I; Sieber F
Photochem Photobiol; 2000 Dec; 72(6):810-4. PubMed ID: 11140270
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
14. Dye-mediated photosensitization of murine neuroblastoma cells.
Sieber F; Sieber-Blum M
Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
[TBL] [Abstract][Full Text] [Related]
16. Eradication of multiple myeloma and breast cancer cells by TH9402-mediated photodynamic therapy: implication for clinical ex vivo purging of autologous stem cell transplants.
Brasseur N; Ménard I; Forget A; el Jastimi R; Hamel R; Molfino NA; van Lier JE
Photochem Photobiol; 2000 Dec; 72(6):780-7. PubMed ID: 11140266
[TBL] [Abstract][Full Text] [Related]
17. [Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells].
Sato Y; Yamazaki T; Yasukawa K; Kaneita Y; Mochimaru J; Hanai M; Irie T; Kura Y; Sawada U; Horie T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2195-200. PubMed ID: 10635304
[TBL] [Abstract][Full Text] [Related]
18. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
19. Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy.
Koenigsmann MP; Notter M; Knauf WU; Papadimitriou CA; Oberberg D; Reufi B; Mücke C; Thiel E; Berdel WE
Bone Marrow Transplant; 1996 Sep; 18(3):549-57. PubMed ID: 8879616
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
Vogler WR; Berdel WE; Olson AC; Winton EF; Heffner LT; Gordon DS
Blood; 1992 Sep; 80(6):1423-9. PubMed ID: 1520869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]